COMPANY
ACF Equity Research

ACF Equity Research
Accuracy | Clarity | Foresight

57
Insights
23.9k
Views
3
Followers
Equities
Refresh
14 Feb 2025 02:40Issuer-paid

NLS Pharmaceutics (NLSP) Core Investment Case 13022025

NLS Pharmaceutics (NLSP:NasdaqCM) is a clinical-stage Swiss foreign issuer biotech advancing the Dual Orexin Receptor Agonist (DOXA) platform

Logo
121 Views
Share
bullishKadimastem
13 Feb 2025 09:49Issuer-paid

Kadimastem (KDST.TA) Core Investment Case 11022025

KDST’s T1D IsletRx program aims to revolutionize insulin production for diabetes patients using off-the-shelf allogeneic encapsulated pancreatic...

Logo
109 Views
Share
05 Feb 2025 22:00Issuer-paid

Sana Biotechnology (SANA) Core Investment Case 05022025

Sana Biotechnology (NasdaqGS:SANA) is a well-funded cell and gene therapy innovator. Its therapies address significant unmet needs across...

Logo
230 Views
Share
04 Dec 2024 07:47Issuer-paid

AsiaFIN Holdings Corp (ASFH) - 3Q24A Beats

AsiaFIN Holdings Corp. (OTCQB : ASFH) - aggressive growth inflection point. ASFH provides IP protected fintech solutions to ASEAN based financial...

Logo
210 Views
Share
12 Nov 2024 22:00Issuer-paid

BrainStorm Cell Therapeutics (BCLI) Update 11112024

BrainStorm Cell Therapeutics Inc. (Nasdaq: BCLI) develops NurOwn® stem cell therapy for NDDs – BCLI’s first target is ALS (MND/Lou...

Logo
161 Views
Share
x